TNNT2 and cancer: ,28 In this report, we aimed to determine the association of baseline levels of biomarkers, hs-cTnT and NT-proBNP, with risk of developing incident cancer among individuals initially free of both clinical CVD and cancer in a multiethnic, geographically diverse cohort.